Zoledronic acid

Zoledronic acid, also known as zoledronate, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget’s disease of bone. It is given by injection into a vein.

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

5,075

Prior Five Years

1,215

Total Citations

Lifetime

90,904

Prior Five Years

8,016

Total Scholars

Lifetime

11,731

Prior Five Years

9,966

Institutional Rankings

Global (Worldwide)

Academic Institutions Lifetime		Academic Institutions Prior Five Years		Non-academic Institutions Lifetime
#1	University of Sheffield United Kingdom	#1	University of Auckland New Zealand	#1	Novartis International AG Switzerland
#2	University of Auckland New Zealand	#2	University of Texas at Austin United States	#2	Institute for Myeloma & Bone Cancer Research United States
#3	Medical University of Vienna Austria	#3	Lund University Sweden	#3	Massachusetts General Hospital United States
#4	Campus Bio-Medico University Italy	#4	University of Oulu Finland	#4	Institut National de la Santé et de la Recherche Médicale France
#5	University of California, Los Angeles United States	#5	Icahn School of Medicine at Mount Sinai United States	#5	Celgene Corporation United States
#6	University of Pittsburgh United States	#6	Tottori University Japan	#6	Amgen Inc. United States
#7	University of Montreal Canada	#7	Minia University Egypt	#7	Pfizer Inc. United States
#8	Pennsylvania State University United States	#8	Aarhus University Denmark		Show More
#9	McMaster University Canada		Show More
#10	KU Leuven Belgium
	Show More

National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime

Prior Five Years

Evaluation Period:

Highly Cited Publications

Lifetime